Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Parnetti

Showing results (211-220 of 283) with videos related to

Pageof 29
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 15, 2026
Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry-based proteomicsMarijke E Stokkel, Lisa Vermunt, Jaco C Knol, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic CharacterizationPiotr Lewczuk, Natalia Lelental, Ingolf Lachmann, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 8, 2011
Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer diseaseMassimo Musicco, Alessandro Padovani, Sandro Sorbi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2014
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's diseaseLucilla Parnetti, Davide Chiasserini, Emanuele Persichetti, et al.
Journal of Alzheimer'S Disease : JAD|May 31, 2013
Estimating the inheritance of frontotemporal lobar degeneration in the Italian populationBarbara Borroni, Mario Grassi, Marta Bianchi, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|January 5, 2012
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALSMarkus Otto, Robert Bowser, Martin Turner, et al.
Biomarkers in Medicine|August 25, 2012
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an updateMarta del Campo, Brit Mollenhauer, Antonio Bertolotto, et al.
International Journal of Alzheimer'S Disease|October 2, 2010
cNEUPRO: Novel Biomarkers for Neurodegenerative DiseasesPhilipp Spitzer, Hans Wolfgang Klafki, Kaj Blennow, et al.
Molecular Neurodegeneration|April 3, 2023
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assaysGiovanni Bellomo, Silvia Paciotti, Luis Concha-Marambio, et al.
Frontiers in Neurology|September 9, 2015
A Practical Guide to Immunoassay Method ValidationUlf Andreasson, Armand Perret-Liaudet, Linda J C van Waalwijk van Doorn, et al.
Pageof 29

Showing results (211-220 of 283) with videos related to

Sort By:
Pageof 29
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 15, 2026
Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry-based proteomicsMarijke E Stokkel, Lisa Vermunt, Jaco C Knol, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic CharacterizationPiotr Lewczuk, Natalia Lelental, Ingolf Lachmann, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 8, 2011
Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer diseaseMassimo Musicco, Alessandro Padovani, Sandro Sorbi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 18, 2014
Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's diseaseLucilla Parnetti, Davide Chiasserini, Emanuele Persichetti, et al.
Journal of Alzheimer'S Disease : JAD|May 31, 2013
Estimating the inheritance of frontotemporal lobar degeneration in the Italian populationBarbara Borroni, Mario Grassi, Marta Bianchi, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|January 5, 2012
Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALSMarkus Otto, Robert Bowser, Martin Turner, et al.
Biomarkers in Medicine|August 25, 2012
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an updateMarta del Campo, Brit Mollenhauer, Antonio Bertolotto, et al.
International Journal of Alzheimer'S Disease|October 2, 2010
cNEUPRO: Novel Biomarkers for Neurodegenerative DiseasesPhilipp Spitzer, Hans Wolfgang Klafki, Kaj Blennow, et al.
Molecular Neurodegeneration|April 3, 2023
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assaysGiovanni Bellomo, Silvia Paciotti, Luis Concha-Marambio, et al.
Frontiers in Neurology|September 9, 2015
A Practical Guide to Immunoassay Method ValidationUlf Andreasson, Armand Perret-Liaudet, Linda J C van Waalwijk van Doorn, et al.
Pageof 29